- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05833334
Healthy Homes Study (HHS)
Co-developing and Pilot Testing a Risk-tailored, Technology-supported Intervention to Increase Home Radon Testing in New Hampshire and Vermont
This study is about home air radon testing and has two phases.
The goal of the first phase is to learn about renters' and homeowners' views and plans related to radon testing. The main question this phase aims to answer is:
1. Does taking part in a focus group with information about radon testing change people's plans to test for radon?
Participants in the first study phase will:
- Take a survey about their views on and plans for radon testing.
- Take part in a focus group discussion about radon testing, during which they will receive information about radon testing.
- Right after the focus group, take a survey about their plans for radon testing.
The second phase is a pilot interventional study. The goal is to test interventions about radon testing with renters and homeowners who smoke and do not smoke. The main questions this phase aims to answer are:
- Does the recruitment strategy result in enough participants enrolling within 3 months?
- Will at least 80% of participants complete data collection activities?
- Will more participants who view an online intervention developed by the researchers request free radon test kits, set them up in their homes, and complete radon testing, compared to participants who view a standard public health infographic? And will even more participants who receive reminder messages, in addition to the online intervention, request free radon test kits, set them up in their homes, and complete radon testing?
Participants in this second phase will:
- Take a survey about their views on and plans for radon testing.
- View an intervention about radon testing.
- Right after viewing the intervention, take a survey about their views on and plans for radon testing.
- 2 months later, take a survey about what, if any, steps they've taken to test their homes for radon.
- Provide the researchers permission to collect data from their State Radon Program on: a) whether they requested a free radon test kit and b) whether testing was completed.
Some participants will receive reminder messages for 2 months after viewing the intervention.
Researchers will compare an online intervention they developed about radon testing to: a) a standard public health infographic and b) their online intervention combined with reminder messages about radon testing. They will compare the interventions by proportion of participants who: a) request a free radon test kit from their State Radon Programs, b) set-up the radon test kit in their homes, and c) complete radon testing.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Stephanie Papas, MPH
- Phone Number: 603-646-5824
- Email: stephanie.papas@dartmouth.edu
Study Contact Backup
- Name: Lisa A Purvis, EdD, MPH
- Phone Number: 603-650-5799
- Email: Lisa.A.Purvis@dartmouth.edu
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Recruiting
- Dartmouth Cancer Center
-
Contact:
- Stephanie Papas, MPH
- Phone Number: 603-646-5824
- Email: stephanie.papas@dartmouth.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Be at least 18 years old
- Have a valid mailing address in New Hampshire or Vermont,
- Have not tested their current homes for radon,
- Rent or own their home, and
- Live at their home year-round
Exclusion Criteria:
- N/A
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Public health infographic (AIM 3)
Participants will view a standard public health infographic about home air radon testing and will receive information about requesting a free home air radon test kit from their state radon program.
|
Standard public health infographic about home air radon testing, plus information about requesting a free home air radon test kit
|
Experimental: Online health promotion intervention tailored by smoking status (AIM 3)
Participants will view an online health promotion intervention about home air radon testing, with messaging tailored based on whether the participant smokes or does not smoke.
Participants will also receive information about requesting a free home air radon test kit from their state radon program.
|
Online health promotion intervention with messaging about home air radon testing tailored by the participant's stated smoking status, plus information about requesting a free home air radon test kit
|
Experimental: Online health promotion intervention tailored by smoking status, plus reminder messages (AIM 3)
Participants will view an online health promotion intervention about home air radon testing, with messaging tailored based on whether the participant smokes or does not smoke.
Participants will also receive information about requesting a free home air radon test kit from their state radon program, as well as reminder messages about radon testing for about two months after initially viewing the online intervention component.
|
Online health promotion intervention with messaging about home air radon testing tailored by the participant's stated smoking status, plus information about requesting a free home air radon test kit, plus reminder messages about home air radon testing sent over two months
|
Experimental: Focus group with educational overview (AIM 1)
Participants will participate in a focus group discussion about radon testing and will receive a brief educational overview about radon testing.
|
90-minute online focus group discussion about home air radon testing, plus an educational overview about home air radon testing using a standard public health infographic
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of participants enrolled in the study (AIM 3)
Time Frame: 3 months
|
Number of participants who consent into the study and meet eligibility criteria within 3 months of study opening to enrollment.
|
3 months
|
Proportion of study participants who complete all study surveys (AIM 3)
Time Frame: 2 months
|
Proportion of study participants who complete all study-related surveys, including the pre-intervention survey, post-intervention survey, and follow-up survey at 2 months post-intervention.
|
2 months
|
Proportion of participants who request a home radon test kit at 18 months (AIM 3)
Time Frame: 18 months
|
Proportion of participants, by study arm, who request a free home radon test kit from the New Hampshire Radon Program or Vermont Radon Program in the 18 months following the intervention, the New Hampshire Radon Program or Vermont Radon Program, as reported by the state radon programs; radon test kits are attributed to participants if the state radon program records match the participant's name and/or address of home residence.
|
18 months
|
Proportion of participants who request a home radon test kit at 2 months (AIM 3)
Time Frame: 2 months
|
Proportion of participants, by study arm, who request a free home radon test kit from the New Hampshire Radon Program or Vermont Radon Program in the 18 months following the intervention, the New Hampshire Radon Program or Vermont Radon Program, as reported by the state radon programs; radon test kits are attributed to participants if the state radon program records match the participant's name and/or address of home residence.
|
2 months
|
Proportion of participants who set-up a home radon test kit in their home (AIM 3)
Time Frame: 2 months
|
Proportion of participants, by study arm, who report setting up the a home radon test kit in their home at two months post-intervention.
|
2 months
|
Proportion of participants who complete home radon testing at 18 months (AIM 3)
Time Frame: 18 months
|
Proportion of participants, by study arm who either: a) report completing radon testing via the follow-up survey at two months post-intervention, or b) submit a home radon test kit for analysis through the New Hampshire Radon Program or Vermont Radon Program, as reported by the state radon programs; radon test kits are attributed to participants if the state radon program records match the participant's name and/or address of home residence.
|
18 months
|
Proportion of participants who complete home radon testing at 2 months (AIM 3)
Time Frame: 2 months
|
Proportion of participants, by study arm who either: a) report completing radon testing via the follow-up survey at two months post-intervention, or b) submit a home radon test kit for analysis through the New Hampshire Radon Program or Vermont Radon Program, as reported by the state radon programs; radon test kits are attributed to participants if the state radon program records match the participant's name and/or address of home residence.
|
2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in participants' intentions to test the air in their homes for radon in the next 12 months (AIM 1)
Time Frame: Baseline (pre-test, approximately 1-4 weeks before intervention), immediately after the intervention (post-test)
|
Intention to test will be measured on a scale of 0 to 10, with 0 indicating they definitely will not test their home air for radon and 10 indicating they definitely will test their home air for radon in the next 12 months.
|
Baseline (pre-test, approximately 1-4 weeks before intervention), immediately after the intervention (post-test)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Judith R Rees, BM, BCh, PhD, Dartmouth-Hitchcock Medical Center
- Principal Investigator: Rian M Hasson, MD, MPH, Dartmouth-Hitchcock Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- STUDY02001931
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lung Cancer
-
M.D. Anderson Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer... and other conditionsUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)RecruitingStage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
Dana-Farber Cancer InstituteMedWaves, IncNot yet recruitingLung Cancer | Lung Cancer Stage I | Lung Cancer Stage II | Stage I Lung Cancer | Stage I - II Primary Lung Cancer | Stage II Lung CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingCaregiver | Stage III Lung Cancer AJCC v7 | Stage I Lung Cancer AJCC v7 | Stage II Lung Cancer AJCC v7 | Stage IB Lung Cancer AJCC v7 | Stage IA Lung Cancer AJCC v7 | Stage IIA Lung Cancer AJCC v7 | Stage IIB Lung Cancer AJCC v7 | Stage IIIA Lung Cancer AJCC v7 | Stage IIIB Lung Cancer AJCC v7United States
-
WindMIL TherapeuticsBristol-Myers SquibbTerminatedNSCLC | Lung Cancer | Lung Cancer Metastatic | Lung Cancer, Non-small Cell | Non Small Cell Lung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non Small Cell Lung Cancer MetastaticUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Genentech, Inc.RecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Lung Non-Small Cell Carcinoma | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung... and other conditionsUnited States
-
Emory UniversityNational Cancer Institute (NCI)TerminatedLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
University of California, San FranciscoMerck Sharp & Dohme LLCWithdrawnLung Non-Small Cell Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage I Lung Cancer AJCC v8 | Stage IA1 Lung Cancer AJCC v8 | Stage IA2 Lung Cancer AJCC v8 | Stage IA3 Lung Cancer AJCC v8 | Stage IB Lung Cancer...United States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Metastatic Lung Carcinoma | Stage IV Lung Cancer AJCC v8 | Head and Neck Carcinoma | Lung Carcinoma | Stage II Lung Cancer AJCC v8 | Stage IIA Lung Cancer AJCC v8 | Stage IIB Lung Cancer AJCC v8 | Stage IIIA Lung... and other conditionsUnited States
Clinical Trials on Public health infographic (AIM 3)
-
Institut BergoniéCompleted
-
University Hospital of SplitCroatian Science FoundationCompletedUnderstanding Cochrane Systematic ReviewsCroatia
-
Institut de Recherche pour le DeveloppementInstitut de Recherche en Sciences de la Sante, Burkina Faso; Expertise France; Institut Pierre RichetRecruitingMalariaBurkina Faso, Côte D'Ivoire
-
Meso Scale Diagnostics, LLC.Centers for Disease Control and PreventionTerminated
-
Ohio State UniversityVidatak, LLCCompletedCritical Illness | Nonverbal CommunicationUnited States
-
Wills EyeJohns Hopkins University; University of Miami; University of Alabama at Birmingham and other collaboratorsCompletedDiabetes Mellitus | Diabetic RetinopathyUnited States
-
Lawson Health Research InstituteCanadian National Institute for the BlindCompleted
-
Meso Scale Diagnostics, LLC.Centers for Disease Control and PreventionCompleted
-
Northwestern UniversityCompleted
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedOrganizational Support for Evidence-based Public HealthUnited States